大约在3、4年前,国外掀起了一个不小的“马兜铃酸风波”。美国联邦食品与药品管理局(FDA)下令禁止含有马兜铃酸的中成药与中药材进口,并停止其销售;法国、加拿大、西班牙、马来西亚和新加坡等国也随之相继发出禁令,从而导致国内的一些中成药生产企业蒙受了重大的经济损失。这引起了国外受众对使用中药安全性的怀疑。2002年2月世界卫生组织国际 About 3 or 4 years ago, there was a big “aristolochic acid wave” in foreign countries. The U.S. Federal Food and Drug Administration (FDA) has ordered the import of proprietary Chinese medicines and Chinese medicinal materials containing aristolochic acid to be banned, and its sales have ceased; France, Canada, Spain, Malaysia, and Singapore have also issued successive bans, resulting in the Some domestic Chinese patent medicine manufacturers have suffered major economic losses. This has caused foreign audiences to doubt the safety of using Chinese medicine. February 2002 World Health Organization International